Aparato digestivo

2017

1. Accuracy of the Ultra-Rapid Urease Test for diagnosis of Helicobacter pylori infection

   Gastroenterologia y Hepatologia, Vol. 40, Núm. 10, pp. 651-657

2. Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance

   World Journal of Gastroenterology, Vol. 23, Núm. 18, pp. 3367-3373

3. Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment

   Digestive Diseases, Vol. 35, Núm. 3, pp. 275-281

4. Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages

   Journal of Hepatology, Vol. 66, Núm. 1, pp. 102-115

5. Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

   Inflammatory Bowel Diseases, Vol. 23, Núm. 8, pp. 1394-1402

6. Colitis quística profunda: informe de 2 casos con 15 años de seguimiento

   Gastroenterologia y Hepatologia, Vol. 40, Núm. 6, pp. 406-408

7. Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain)

   World Journal of Gastroenterology, Vol. 23, Núm. 15, pp. 2731-2742

8. Consumo de cannabis e invaginaciones intestinales. ¿Una asociación casual?

   Revista Espanola de Enfermedades Digestivas, Vol. 109, Núm. 2, pp. 157-159

9. Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs

   United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260

10. Early tuberculin skin test for the diagnosis of latent tuberculosis infection in patients with inflammatory Bowel disease

    Journal of Crohn's and Colitis, Vol. 11, Núm. 7, pp. 792-800

11. Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

    Journal of Gastroenterology, Vol. 52, Núm. 7, pp. 788-799

12. Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

    American Journal of Gastroenterology, Vol. 112, Núm. 1, pp. 120-131

13. Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry

    American Journal of Gastroenterology, Vol. 112, Núm. 7, pp. 1135-1143

14. Granulocyte-Monocyte Apheresis as an Adjuvant Therapy to Anti-Tumor Necrosis Factor Drugs for Ulcerative Colitis

    Therapeutic Apheresis and Dialysis, Vol. 21, Núm. 1, pp. 26-30

15. Hepatitis sifilítica: : una entidad poco frecuente

    Revista andaluza de patología digestiva, Vol. 40, Núm. 1, pp. 57-58

16. Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives

    Gastroenterology, Vol. 153, Núm. 1, pp. 106-112.e2

17. Influencia de la presión arterial al inicio de las descompensaciones en el pronóstico de pacientes con insuficiencia cardiaca

    Medicina Clinica, Vol. 149, Núm. 4, pp. 147-152

18. Liver Iron concentration in patients referred to a secondary hospital for hyperferritinemia: Analysis of the different groups according to HFE mutations and the transferrin saturation index

    Hepatitis Monthly, Vol. 17, Núm. 1, pp. 1-5

19. Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study

    American Journal of Gastroenterology, Vol. 112, Núm. 11, pp. 1709-1718

20. Molecular mechanisms of cholangiocarcinogenesis: New potential targets for therapy

    Current Drug Targets, Vol. 18, Núm. 8, pp. 932-949